Follow up survey for implementation of fixed-dosing of monoclonal antibodies
Follow up survey for implementation of fixed-dosing of monoclonal antibodies
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Similar to the earlier anti-cancer therapies, monoclonal antibodies were introduced in bodysize-based schedules, despite the fact that body size only modestly effects the distribution, elimination and efficacy of monoclonal antibodies. Fixed-dosing of nivolumab and pembrolizumab has recently been approved by the European Medicines Age...
Alternative Titles
Full title
Follow up survey for implementation of fixed-dosing of monoclonal antibodies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2352054032
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2352054032
Other Identifiers
ISSN
2210-7703
E-ISSN
2210-7711
DOI
10.1007/s11096-020-00971-z
